Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor - PubMed (original) (raw)
. 2000 Jul 15;60(14):3696-700.
Affiliations
- PMID: 10919635
Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor
A Marrogi et al. Cancer Res. 2000.
Abstract
Accumulating data demonstrate overexpression of both inducible NO synthase (NOS2) and cyclooxygenase-2 (COX2) in many epithelial neoplasias. In addition, cyclooxygenase inhibitors have been shown to have antineoplastic and prophylactic efficacy against human colon cancer and in mouse models of this disease. Mesothelioma arises in a context of asbestos exposure and chronic inflammation, which would be expected to enhance the expression of these inducible enzymes. This study demonstrates that both inducible enzymes were expressed in 30 human mesothelioma tissues but were not detectable in nonreactive mesothelial tissues from the same individuals. In contrast, areas of reactive mesothelial cells stained positively for these enzymes. In vitro exposure of human mesothelioma cell lines to the COX2 inhibitor, NS398, revealed dose- and time-dependent antiproliferative activity, whereas the NOS2 inhibitor, 1400W, had no detectable inhibitory effect. Surprisingly, nonmalignant human mesothelial isolates expressed both NOS2 and COX2 in vitro at the same level as mesothelioma cell lines but were less sensitive to NS398 inhibition. This finding indicates that these nonmalignant isolates may retain properties of reactive mesothelial cells and suggests that targets in addition to COX2 may be involved in the antiproliferative response of mesothelioma cell lines. These results have clinical significance because of the selective activity of the drug coupled with the therapeutic resistance and poor prognosis of mesothelioma. The findings presented here suggest that further preclinical studies of these inhibitors in animal models of mesothelioma would be of great interest.
Similar articles
- Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M. Hu KQ, et al. Int J Oncol. 2003 Apr;22(4):757-63. Int J Oncol. 2003. PMID: 12632065 - COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Liao Z, Milas L. Liao Z, et al. Expert Rev Anticancer Ther. 2004 Aug;4(4):543-60. doi: 10.1586/14737140.4.4.543. Expert Rev Anticancer Ther. 2004. PMID: 15270659 Review. - Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM. Moran EM. J Environ Pathol Toxicol Oncol. 2002;21(2):193-201. J Environ Pathol Toxicol Oncol. 2002. PMID: 12086406 Review.
Cited by
- Role of nuclear factor-ĸB in breast and colorectal cancer.
Zubair A, Frieri M. Zubair A, et al. Curr Allergy Asthma Rep. 2013 Feb;13(1):44-9. doi: 10.1007/s11882-012-0300-5. Curr Allergy Asthma Rep. 2013. PMID: 22956391 Review. - Apoptotic Effect of Tolfenamic Acid in KB Human Oral Cancer Cells: Possible Involvement of the p38 MAPK Pathway.
Kim JH, Jung JY, Shim JH, Kim J, Choi KH, Shin JA, Choi ES, Lee SO, Chintharlapalli S, Kwon KH, Leem DH, Cho NP, Cho SD. Kim JH, et al. J Clin Biochem Nutr. 2010 Jul;47(1):74-80. doi: 10.3164/jcbn.10-02. Epub 2010 Jun 17. J Clin Biochem Nutr. 2010. PMID: 20664734 Free PMC article. - Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.
Tian G, Yu JP, Luo HS, Yu BP, Yue H, Li JY, Mei Q. Tian G, et al. World J Gastroenterol. 2002 Jun;8(3):483-7. doi: 10.3748/wjg.v8.i3.483. World J Gastroenterol. 2002. PMID: 12046075 Free PMC article. - Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.
Vogl M, Rosenmayr A, Bohanes T, Scheed A, Brndiar M, Stubenberger E, Ghanim B. Vogl M, et al. Cancers (Basel). 2021 Feb 6;13(4):658. doi: 10.3390/cancers13040658. Cancers (Basel). 2021. PMID: 33562138 Free PMC article. Review. - PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P. Obermajer N, et al. Cancer Res. 2011 Dec 15;71(24):7463-70. doi: 10.1158/0008-5472.CAN-11-2449. Epub 2011 Oct 24. Cancer Res. 2011. PMID: 22025564 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials